New-Onset Hyperglycemia and Acute Coronary Syndrome: A Systematic Overview and Meta-Analysis
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Patients without a history of diabetes often develop hyperglycemia during an acute coronary syndrome (ACS). New onset of hyperglycemia (NH) is associated with higher mortality both in the short and long-term. AIM: We performed a systematic review and meta-analysis of observational studies to investigate the association between NH and mortality in patients with ACS. In-hospital, 30-day and long-term mortality were analyzed separately. METHODS: We searched MEDLINE for prospective studies of patients with ACS reporting the association between NH and mortality, using Research Methodology Filters. This was supplemented by hand searching reference lists of retrieved articles. We determined study eligibility and conducted data abstraction independently and disagreements were resolved by consensus. We pooled odds ratios (OR) from individual studies using a random effects model. RESULTS: Our search strategy identified 24 studies. The prevalence of NH varied widely 3% to 71% depending on the definition of NH used. NH significantly increased the risk of in-hospital (OR 3.62, 95% CI: 3.09 - 4.24; p < 0.0001, I2=0.0%; 15 studies, 10673 patients), 30-day (OR 4.81, 95% CI: 2.18 - 10.61, p < 0.0001, I2=92.2%; 4 studies, 101447 patients), and long-term (up to 108 months) mortality (OR 2.02, 95% CI: 1.62-2.51; p < 0.0001, I2=79.4%; 12 studies, 102099 patients). CONCLUSIONS: In patients without a prior diagnosis of diabetes who are admitted to hospital for ACS, NH increases the risk of both short and long-term mortality. These data highlight the need for further studies addressing the control of blood glucose levels in patients with ACS. SUMMARY: Patients without history of diabetes may develop new hyperglycemia (NH) on admission to hospital for AMI. We systematically reviewed the prognostic impact of NH on short- and long-term mortality in patients without prior diagnosis of diabetes who attended the hospital for ACS. We identified 24 outcome studies which met a set of pre-specified criteria. Prevalence of NH ranged from 3% to 71% according to different thresholds of blood glucose concentrations. NH significantly increased the risk of in-hospital (OR 3.62, 95% CI: 3.09 - 4.24; p < 0.0001, I2=0.0%; 15 studies, 10673 patients), 30-day (OR 4.81, 95% CI: 2.18 - 10.61, p < 0.0001, I2=92.2%; 4 studies, 101447 patients)), and long-term (up to 108 months) mortality (OR 2.02, 95% CI: 1.62-2.51; p < 0.0001, I2=79.4%; 12 studies, 102,099 patients).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mortality correlates more strongly to the blood glucose level than to the presence of diabetes.419,420”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [420]
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · cited 2×
“Typically, values above 50% are deemed to suggest large between-study heterogeneity, values of 25–50% are deemed to show modest heterogeneity, and values below 25% denote low heterogeneity [7].”
BackgroundMethodIntensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119 · cited 2×
“In the recent Normoglycemia in Intensive Care Evaluation–Survival Using Glucose Algorithm Regulation (NICESUGAR) study on intensive insulin therapy [48], a tight glucose control (4.”
MethodHow should meta‐regression analyses be undertaken and interpreted?
Thompson, S. G., & Higgins, J. P. T. (2002) · Statistics in Medicine · doi:10.1002/sim.1187 · Cited by 3,026 · cited 2×
“This method uses each study’s estimate and its standard error to separate within-study from between-study variability [10].”
MethodCapes, S. E., Hunt, D., Malmberg, K., & Gerstein, H. C. (2000) · The Lancet · doi:10.1016/s0140-6736(99)08415-9 · Cited by 2,187 · cited 1×
“[35].”
(2000) · Queen Mary Research Online (Queen Mary University of London) · Cited by 1,795
Malmberg, K. (1997) · BMJ · doi:10.1136/bmj.314.7093.1512 · Cited by 1,286
Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus
Buse, J. B., Ginsberg, H. N., Bakris, G. L., Clark, N. G., Costa, F., Eckel, R., Fonseca, V., Gerstein, H. C., Grundy, S., Nesto, R. W., et al. (2007) · Diabetes Care · doi:10.2337/dc07-9917 · Cited by 1,055 · cited 1×
“Diabetic patients have a 2-to-4 times higher coronary artery disease (CAD) or stroke death rate [1, 2].”
BackgroundMalmberg, K., Rydén, L., Wedel, H., Birkeland, K., Bootsma, A., Dickstein, K., Efendic, S., Fisher, M., Hamsten, A., Herlitz, J., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi199 · Cited by 1,048
Malmberg, K., Norhammar, A., Wedel, H., & Rydén, L. (1999) · Circulation · doi:10.1161/01.cir.99.20.2626 · Cited by 847
Developing Optimal Search Strategies for Detecting Clinically Sound Studies in MEDLINE
Haynes, R. B., Wilczynski, N., McKibbon, K. A., Walker, C. J., & Sinclair, J. C. (1994) · Journal of the American Medical Informatics Association · doi:10.1136/jamia.1994.95153434 · Cited by 765 · cited 1×
“We searched for eligible studies, using research Methodology Filters (see appendix) [5].”
Method
Cited by
2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
Swaddling and the Risk of Sudden Infant Death Syndrome: A Meta-analysis
Pease, A. S., Fleming, P. J., Hauck, F. R., Moon, R. Y., Horne, R. S. C., L’Hoir, M. P., Ponsonby, A.-L., & Blair, P. S. (2016) · Pediatrics · doi:10.1542/peds.2015-3275 · Cited by 161
Hyperglycemia in acute coronary syndromes: from mechanisms to prognostic implications
Angeli, F., Reboldi, G., Poltronieri, C., Lazzari, L., Sordi, M., Garofoli, M., Bartolini, C., & Verdecchia, P. (2015) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944715594528 · Cited by 98
“Regardless of its classification, prevalence of hyperglycemia in different epidemiological studies (Table 1) ranges from 3% to 71% of patients admitted with ACS [Angeli et al. 2010, 2013].”
BackgroundMethodResultInfluentialSelf-citationZuo, Y.-Y., Kang, Y., Yin, W., Wang, B., & Chen, Y. (2012) · Journal of Critical Care · doi:10.1016/j.jcrc.2011.12.004 · Cited by 38
Ye, Y., Xie, H., Zhao, X., & Zhang, S. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-155 · Cited by 27
“Introduction Numerous studies have demonstrated that hyperglycemia is common among patients with acute coronary syndrome (ACS) [1,2], and the relationship between hyperglycemia and increased mortality risk in ACS has been well established across various glucose metrics [3,4].”
BackgroundAliz, E. L., Moreno-Martínez, F. L., Pérez-Fernández, G. A., Fleites, L. F. V., & Rabassa-López-Calleja, M. A. (2014) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2014.01.002 · Cited by 24
Wei, C. H., & Litwin, S. E. (2014) · Diabetes · doi:10.2337/db14-0571 · Cited by 25
Singh, A. K., & Singh, R. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.08.034 · Cited by 19
“Notably, atadmission hyperglycemia has often been linked to a poorer clinical outcome during the critical illnesses [3,4], acute coronary syndrome [5,6] and revascularization procedures [7,8].”
BackgroundCarvalho, R. C., Nishi, F. A., Ribeiro, T. B., França, G. G., & Aguiar, P. M. (2020) · Current Diabetes Reviews · doi:10.2174/1573399816666200130093523 · Cited by 20
Sáez, M. E., Smani, T., Ramírez‐Lorca, R., Díaz, I., Serrano‐Ríos, M., Ruiz, A., & Ordóñez, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019327 · Cited by 16
Management of acute coronary syndromes
Tardif, J.-C., L'Allier, P. L., & Fitchett, D. H. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.029 · Cited by 10
Management of Acute Coronary Syndromes
Tardif, J., L'Allier, P. L., & FITCHETT, D. H. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.034 · Cited by 10
Medical emergencies: atrial fibrillation and myocardial infarction
Somasundaram, K., & Ball, J. (2012) · Anaesthesia · doi:10.1111/anae.12050 · Cited by 11
“Both hyperglycaemia and high blood glucose variability are markers of severity of illness and associated with a worse outcome in patients with ACS [80].”
BackgroundPanduranga, P., Sulaiman, K., Al‐Lawati, J., & Al-Zakwani, I. S. (2011) · Heart Views · doi:10.4103/1995-705x.81554 · Cited by 12
Jomaa, W., Mhamdi, S. E., Ali, I. B., Azaiez, M. A., Hraïech, A. E., Hamda, K. B., & Maatouk, F. (2018) · Indian Heart Journal · doi:10.1016/j.ihj.2018.01.005 · Cited by 13
“Although declining, short and long term mortality rates in patients presenting for ST-elevation myocardial infarction (STEMI) remain highly preoccupying.1 Compared to non-diabetic patients, diabetic ones are known to carry worse early and late outcomes.2 On the other hand, and depending on the definition used, prevale…”
ResultInfluentialThalib, L., Zubaid, M., Rashed, W. A., Suwaidi, J. M. S. A., Almahmeed, W. A., Al‐Ozairi, E., Alanbaei, M., Sulaiman, K., Amin, H., & Al‐Motarreb, A. (2010) · Clinical Medicine & Research · doi:10.3121/cmr.2010.946 · Cited by 11
“Several studies over the last decade have linked hyperglycemia at the time of hospital admission with subsequent higher mortality in patients with acute coronary syndrome (ACS), including acute myocardial infarction (AMI).(1-7) There is also some evidence linking hyperglycemia with increased incidence of stroke and ot…”
BackgroundBouida, W., Beltaïef, K., Msolli, M. A., Bzeouich, N., Sekma, A., Echeikh, M., Mzali, M., Boubaker, H., Grissa, M. H., Boukef, R., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006674 · Cited by 6
“21 Patients were eligible for inclusion if they presented with non – ST-segment elevation with ischemic symptoms lasting ≥ 10 minutes without persistent ST-segment elevation on ECG and had at least one of the following: ischemic ECG changes ( ≥ 2 leads demonstrating ST depression ≥ 0.5 mV, T-wave…”
InfluentialUllah, M., Sayami, L., Khan, M., Jahan, A., Rahman, Z., Rahman, M. T., & Majumder, A. (1970) · Cardiovascular Journal · doi:10.3329/cardio.v3i2.9183 · Cited by 7
Pu, J., Zhang, H., Wang, F., Zhou, Y., Liu, D., Wang, H., Shi, T., Yang, S., Yang, F., & Chen, L. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm26065 · Cited by 6
Terlecki, M., Kocowska‐Trytko, M., Pavlinec, C., Ostrowska, A., Lis, P., Bednarski, A., Wojciechowska, W., Stolarz‐Skrzypek, K., & Rajzer, M. (2023) · Cardiology Journal · doi:10.5603/cj.a2023.0041 · Cited by 6
The future of inpatient diabetes management: glucose as the sixth vital sign
Rendell, M., Saiprasad, S., Trepp-Carrasco, A. G., & Drincic, A. (2013) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.13.1 · Cited by 6
Catheter-based renal artery denervation: facts and expectations
Verdecchia, P., Cavallini, C., Sclafani, R., Santucci, A., Notaristefano, F., Zingarini, G., Colombo, G., & Angeli, F. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.07.041 · Cited by 6
Self-citationCare of acute myocardial infarction in the coronary care units of Piedmont in 2007
Steffenino, G. D., Chinaglia, A., Noussan, P., Alciati, M., Bongioanni, S., Rolfo, C., Soldà, P. L., Gnavi, R., Picariello, R., & Orlando, A. (2013) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32835422f8 · Cited by 3
Dietary Adherence in Type 1 and 2 Diabetes
Heilig, C. W. (2013) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000e111 · Cited by 3
“In particular, an association between hyperglycemia and increased mortality and in-hospital complications in the time of acute coronary syndromes (ACS) has been confirmed in different studies [4,5].”
BackgroundMethodResultDillinger, J., Achkouty, G., Albert, F., Müller, G., Labèque, J.-N., Moisson, L., Morelle, J., Cottin, Y., Pezel, T., Lim, P., et al. (2022) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2022.02.004 · Cited by 3
Yao, H., Ekou, A. K., Niamkey, T., Touré, C., Guénancia, C., Kouame, I., Gbassi, C., Konin, C. K., & N’Guetta, R. (2020) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2020-028 · Cited by 3
[Management of hyperglycemia in hospitalized patients].
Gracia‐Ramos, A. E., Cruz-Domínguez, M. P., Madrigal‐Santillán, E., Morales‐González, J. A., & Lastra, O. L. V. (2015) · PubMed · Cited by 3
[Association of stress hyperglycemia and in-hospital complications].
Galindo-García, G., Galván-Plata, M. E., Nellen-Hummel, H., & Almeida‐Gutiérrez, E. (2015) · PubMed · Cited by 2
The Impact of Glyco-Metabolic Status in Patients Treated for Acute Coronary Syndrome
Vavlukis, M., Zafirovska, B., Antova, E., Pocesta, B., Shehu, E., Taravari, H., Kotlar, I., Kitanovski, D., Petkoska, D., Vasilev, I., et al. (2018) · PRILOZI · doi:10.2478/prilozi-2018-0022 · Cited by 2
Çakır, A., Akyol, P. Y., & Acar, H. (2022) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-022-03182-9 · Cited by 2
New Perspectives and Strategies for the Management of Hypertension
Angeli, F. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10080346 · Cited by 1
“They discuss the role of artificial intelligence [16], the prognostic value of a tight BP control in chronic kidney disease [17], implications of endothelial dysfunction as therapeutic target [18] in hypertension and other conditions [19], the link between hypertension and cardiac arrhythmias [20,21], and recent advan…”
BackgroundSelf-citationA Case Series of Concomitant Treatment of Perhexiline With Amiodarone
Gilutz, H., Frenneaux, M. P., & Horowitz, J. D. (2012) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e318245e5a6 · Cited by 1
Conventional insulinvsinsulin infusion therapy in acute coronary syndrome diabetic patients
Arvia, C., Siciliano, V., Chatzianagnostou, K., Laws, G., Galvan, A. Q., Mammini, C., Berti, S., Molinaro, S., & Iervasi, G. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i4.562 · Cited by 1
Medical management of acute coronary syndromes
Ciffone, N. A., & Dokken, B. B. (2017) · Journal of the American Association of Nurse Practitioners · doi:10.1002/2327-6924.12457 · Cited by 5
“Independent of a diagnosis of diabetes, hyperglycemia upon presentation is associated with increased shortand long-term mortality among ACS patients (Angeli et al., 2010).”
BackgroundAscaso, J. F. (2014) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2014.06.001 · Cited by 1
EVALUATION OF ADMISSION TIME HYPERGLYCAEMIA IN ACUTE CORONARY SYNDROME PATIENTS
Chaudhary, V. R., Aundhakar, S. C., Afzalpurkar, S., Prajapati, P., Prajapati, S., Desai, A., Gandhi, S., & Patil, O. (2017) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2017/359 · Cited by 1
“DISCUSSION Hyperglycaemia at the time of hospital admission predicts increased mortality in patients with Acute Coronary Syndromes (ACS) including ST-Segment Elevation Myocardial Infarction (STEMI),(10-15) revascularisation procedures such as thrombolysis or Percutaneous Coronary Intervention (PCI),(16-19) and other c…”
Raharinavalona, S. A., Raherison, R. E., Razanamparany, T., Randrianomanana, T. V., & Rakotomalala, A. D. P. (2022) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.383
Glicemia na ressuscitação cardiopulmonar
Palácio, M. Â. G. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.98.2011.tde-06102011-075431
Glycaemic control for patients with acute coronary syndrome
Andriolo, R. B., Ponte, J. R., Jr., Gutierrez, E. G., Andriolo, B. N., & Ramos, L. R. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010811.pub2
Prise en charge des syndromes coronariens aigus
Tardif, J., L'Allier, P. L., & FITCHETT, D. H. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.07.017
Fernández, G. A. P., & Aliz, E. L. (2011) · DOAJ (DOAJ: Directory of Open Access Journals)
Prognostic value of serum parathyroid hormone in ST-elevation myocardial infarction patients
Obradovic, S. D., Vukotić, S., Banovic, M. D., Džudović, B., Marinković, J., Vujanić, S., & Obradović, D. (2016) · Vojnosanitetski pregled · doi:10.2298/vsp150816108o
Falguera, N. T. (2016) · UPCommons institutional repository (Universitat Politècnica de Catalunya) · doi:10.5821/dissertation-2117-105139 · Cited by 3
Glycaemic control for patients with acute coronary syndrome
Andriolo, R. B., Ponte, J. R., Jr., Gutierrez, E. G., Silva, B. N., & Ramos, L. R. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010811
RetractedThe Management of Hyperglycemia and DM in Patients with an Acute Coronary Syndrome
Joseph, T., & Johnstone, M. T. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-13177-6_24
Fasting glycemia: prognostic value in the immediate evolution of women with acute coronary síndrome
González, D. R. M., Rodríguez, L. O. C., & Jiménez, E. L. M. (2023) · Health Leadership and Quality of Life · doi:10.56294/hl2023198
Ren, J., Wang, G. X., Zhou, Y., Gong, W., Zhang, H., & Yan, Y. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2549412
“…in tailoring effective interventions for those at risk of progressing to diabetes. in patients presenting with acute coronary syndrome (aCS), elevated blood glucose levels at hospital admission are associated with an increased risk of mortality, regardless of whether the patient has diabetes [3].”
Hoa*, L. T., Cường, T. Q., Thạch*, T. Đ. H. Y. K. P. N., & Nhất, B. V. T. (2016) · Tạp chí Tim Mạch Học Việt Nam · doi:10.58354/jvc.7576.2016.1006
Metadata
- Authors
- Angeli, F., Verdecchia, P., Karthikeyan, G., Mazzotta, G., Pinto, M., Repaci, S., Gatteschi, C., Gentile, G., Cavallini, C., & Reboldi, G.
- Corresponding author
- Verdecchia, Paolo
- Reboldi, Gianpaolo
- ORCID
- Venue
- Current Diabetes Reviews
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2010-03-01
- Volume
- 6
- Issue
- 2
- Pages
- 102-110
- ISSN
- 1573-3998 (ISSN-L)
- OpenAlex
- W2114325741
- Cited by
- 48
- References
- 44
- Citations by year
- 2025: 2 · 2023: 6 · 2022: 3 · 2020: 3 · 2018: 3 · 2017: 3 · 2016: 5 · 2015: 3 · 2014: 4 · 2013: 6 · 2012: 4
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Diabetes Reviews (publishedVersion)
- PubMed (publishedVersion)
- IrInSubria (University of Insubria) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- acute coronary syndrome, mortality, in-hospital mortality, 30-day mortality, long-term mortality, non-diabetic patients, glycemic control, myocardial infarction, prognostic factors
- MeSH terms
- Adult, Aged, Aged, 80 and over, Blood Glucose, Humans, Hyperglycemia, Patient Admission, Prognosis, Hospital Mortality, Diabetes Complications, Acute Coronary Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.